Exposure of hemodialysis patients to di-2-ethylhexyl phthalate.

[1]  T. Mettang,et al.  Uraemic pruritus and exposure to di(2-ethylhexyl)phthalate (DEHP) in haemodialysis patients , 1996 .

[2]  T. Mettang,et al.  The Fate of Leached Di(2-Ethylhexyl)Phthalate in Patients Undergoing Capd Treatment , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  M. Luyckx,et al.  Stability, compatibility and plasticizer extraction of miconazole injection added to infusion solutions and stored in PVC containers. , 1995, Journal of pharmaceutical and biomedical analysis.

[4]  S. K. Kang,et al.  A Comparative Study of Platelets Stored in Polyvinyl Chloride Containers Plasticised with Butyryl Trihexyl Citrate or Triethylhexyl Trimellitate , 1995, Vox sanguinis.

[5]  T. Watanabe,et al.  Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. , 1995, Cancer letters.

[6]  K. Knights,et al.  Differential induction of rat hepatic microsomal and peroxisomal long-chain and nafenopin-CoA ligases by clofibric acid and di-(2-ethylhexyl)phthalate. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  Z. Rácz,et al.  Effect of DEHP Plasticizer on Stored Platelets , 1995, Vox sanguinis.

[8]  M. Badr,et al.  Mechanism of phthalate-induced inhibition of hepatic mitochondrial β-oxidation , 1995 .

[9]  H. K. Bojes,et al.  Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. , 1994, Toxicology and applied pharmacology.

[10]  H. Nau,et al.  Exposure of newborn infants to di‐(2‐ethylhexyl)‐phthalate and 2‐ ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters , 1993, Transfusion.

[11]  C. Elcombe,et al.  In vitro inhibition of carnitine acyltransferase activity in mitochondria from rat and mouse liver by a diethylhexylphthalate metabolite. , 1993, Biochemical pharmacology.

[12]  H. Dirven,et al.  Metabolites of the plasticizer di (2-ethylhexyl) phthalate in urine samples of workers in polyvinylchloride processing industries , 1993, International archives of occupational and environmental health.

[13]  H. Dirven,et al.  Determination of four metabolites of the plasticizer di (2-ethylhexyl) phthalate in human urine samples , 1993, International archives of occupational and environmental health.

[14]  J. Noordhoek,et al.  Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. , 1992, Biochemical pharmacology.

[15]  J. Okita,et al.  Characterization of a cytochrome P450 from di(2-ethylhexyl) phthalate-treated rats which hydroxylates fatty acids. , 1992, Archives of biochemistry and biophysics.

[16]  A. Christensson,et al.  In vivo Comparative Evaluation of Hemodialysis Tubing Plasticized with DEHP and TEHTM , 1991, The International journal of artificial organs.

[17]  V. Stella,et al.  Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. , 1991, American journal of hospital pharmacy.

[18]  M. Luyckx,et al.  Rapid determination by high performance liquid chromatography of di-2-ethylhexyl phthalate in plasma stored in plastic bags. , 1991, Biomedical chromatography : BMC.

[19]  J. Reddy Carcinogenicity of peroxisome proliferators: evaluation and mechanisms. , 1990, Biochemical Society transactions.

[20]  W. Keon,et al.  Perioperative exposure to plasticizers in patients undergoing cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.

[21]  R. Cattley,et al.  Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. , 1989, Carcinogenesis.

[22]  R. Cattley,et al.  Possible Mechanisms in Hepatocarcinogensis by the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate , 1989 .

[23]  R. Bergia,et al.  The fate of leached di-(2-ethylhexyl)-phthalate (DEHP) in patients on chronic haemodialysis. , 1988, The International journal of artificial organs.

[24]  B. Lake,et al.  Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. , 1988, Biochemical pharmacology.

[25]  L. Nässberger,et al.  Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. , 1987, Nephron.

[26]  C. Elcombe,et al.  Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. , 1986, Environmental health perspectives.

[27]  C. S. Giam,et al.  Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous cyclosporine solution. , 1986, American journal of hospital pharmacy.

[28]  M. Allwood The release of phthallate ester plasticizer from intravenous administration sets into fat emulsion , 1986 .

[29]  S. Jacobsson,et al.  Studies on contamination of intravenous solutions from PVC-bags with dynamic headspace GC-MS and LC-diode array techniques , 1986 .

[30]  U. Bondesson,et al.  Exposure of newborn infants to plasticizers: Plasma levels of di‐(2‐ ethylhexyl) phthalate and mono‐(2‐ethylhexyl) phthalate during exchange transfusion , 1985, Transfusion.

[31]  D. Shen,et al.  Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. , 1985, Toxicology and applied pharmacology.

[32]  Y. Nakamura,et al.  Teratogenicity/fetotoxicity of DEHP in mice. , 1982, Environmental health perspectives.

[33]  J. F. Douglas,et al.  The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. , 1982, Journal of toxicology and environmental health.

[34]  S. Nakamoto,et al.  Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients. , 1978, Clinical Chemistry.

[35]  T. Gibson,et al.  Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis. , 1976, The Journal of laboratory and clinical medicine.